Yamada K - Search Results

1

[Phase I study and early phase II of SM-108 (4-carbamoylimidazolium-5-olate) in lung cancer. SM-108 Study Group].

Kimura K, Suzuoki Y, Ogawa M, Miyazaki T, Uzuka Y, Sakai Y, Ohno R, Yamada K, Ota K, Yoshida T, et al. Kimura K, et al. Among authors: yamada k. Gan To Kagaku Ryoho. 1989 Jan;16(1):113-21. Gan To Kagaku Ryoho. 1989. PMID: 2643391 Clinical Trial. Japanese.

2

[Late phase II study of MST-16 (sobuzoxane) on malignant lymphoma].

Yamada K, Ohno R, Oguri T, Kamiya O, Yokomaku S, Kobayashi M, Nishiwaki H, Tanaka M, Inagaki J, Mitomo Y, et al. Yamada K, et al. Gan To Kagaku Ryoho. 1991 Nov;18(14):2447-52. Gan To Kagaku Ryoho. 1991. PMID: 1952964 Japanese.

3

[Phase II study of SM-108 (4-carbamoylimidazolium-5-olate) in hematological malignancies].

Kimura K, Yamada K, Uzuka Y, Masaoka T, Hirano M, Ohno R, Ogawa M. Kimura K, et al. Among authors: yamada k. Gan To Kagaku Ryoho. 1989 Jan;16(1):123-30. Gan To Kagaku Ryoho. 1989. PMID: 2643392 Clinical Trial. Japanese.

4

[Phase I clinical study of NK 171 (etoposide)].

Kimura K, Yamada K, Niitani H. Kimura K, et al. Among authors: yamada k. Gan To Kagaku Ryoho. 1985 Apr;12(4):851-6. Gan To Kagaku Ryoho. 1985. PMID: 2985006 Clinical Trial. Japanese.

5

[Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].

Tatsumi N, Yamada K, Ohshima T, Nakamura T, Ohno R, Masaoka T, Kimura I, Kimura K. Tatsumi N, et al. Among authors: yamada k. Gan To Kagaku Ryoho. 1990 Dec;17(12):2387-95. Gan To Kagaku Ryoho. 1990. PMID: 2260876 Clinical Trial. Japanese.

6

Phase II study: treatment of non-Hodgkin's lymphoma with an oral antitumor derivative of bis(2,6-dioxopiperazine).

Ohno R, Yamada K, Hirano M, Shirakawa S, Tanaka M, Oguri T, Kodera Y, Mitomo Y, Ikeda Y, Yokomaku S, et al. Ohno R, et al. Among authors: yamada k. J Natl Cancer Inst. 1992 Mar 18;84(6):435-8. doi: 10.1093/jnci/84.6.435. J Natl Cancer Inst. 1992. PMID: 1538420 Clinical Trial.

7

[A pharmacokinetic study of idarubicin hydrochloride, a new anthracycline anti-tumor drug, in patients with acute leukemia. Idarubicin Study Group].

Fujita H, Ogawa M, Masaoka T, Yamada K, Kimura K. Fujita H, et al. Among authors: yamada k. Gan To Kagaku Ryoho. 1992 Jun;19(6):791-8. Gan To Kagaku Ryoho. 1992. PMID: 1605655 Japanese.

8

Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumor agent, MST-16.

Ichihashi T, Kiyoi H, Fukutani H, Kubo K, Yamauchi T, Naoe T, Yamada K, Ohno R. Ichihashi T, et al. Among authors: yamada k. Oncology. 1992;49(5):333-5. doi: 10.1159/000227067. Oncology. 1992. PMID: 1528567 Clinical Trial.

9

A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia-lymphoma.

Ezaki K, Hirano M, Ohno R, Yamada K, Naito K, Hirota Y, Shirakawa S, Kimura K. Ezaki K, et al. Among authors: yamada k. Cancer. 1991 Aug 15;68(4):695-8. doi: 10.1002/1097-0142(19910815)68:4<695::aid-cncr2820680405>3.0.co;2-k. Cancer. 1991. PMID: 1855169 Clinical Trial.

10

[Recent progress in the treatment of hematological malignancies II. Acute nonlymphocytic leukemia in adult].

Kimura K, Yamada K. Kimura K, et al. Among authors: yamada k. Nihon Naika Gakkai Zasshi. 1989 Jun;78(6):765-8. Nihon Naika Gakkai Zasshi. 1989. PMID: 2794657 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,313 results

Search Page

Filters